藥華藥 (6446) 每月營收 財報分析

台股 » 藥華藥 » 個股財報 » 每月營收

藥華藥

(6446)

可現股當沖

股價
508
漲跌
▼21
漲幅
-3.97%
成交量
3,148張
產業
上市生技醫療類股 ▼0.76%
本地時間:14:30

319人加入追蹤

立即追蹤

藥華藥 (6446) 財務報表－每月營收

月營收報表

因應IFRSs國際會計準則，本報表在2013年以前為「個別營收」，2013年以後為「合併營收」。

藥華藥 (6446) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2025/05	1,179,267	790,639	-3.8%	49.2%	5,662,726	3,111,498	82%
2025/04	1,226,153	667,420	3.9%	83.7%	4,483,459	2,320,859	93.2%
2025/03	1,180,523	558,040	15.5%	111.5%	3,257,306	1,653,438	97%
2025/02	1,021,672	587,814	-3.2%	73.8%	2,076,783	1,095,399	89.6%
2025/01	1,055,111	507,585	-10%	107.9%	1,055,111	507,585	107.9%
2024/12	1,172,972	674,560	15.5%	73.9%	9,775,727	5,105,615	91.5%
2024/11	1,015,187	424,890	11%	138.9%	8,602,755	4,431,055	94.1%
2024/10	914,288	547,405	-1.9%	67%	7,587,568	4,006,165	89.4%
2024/09	932,418	401,815	3.4%	132.1%	6,673,280	3,458,760	92.9%
2024/08	901,338	458,657	2.5%	96.5%	5,740,862	3,056,944	87.8%
2024/07	879,603	445,805	3.7%	97.3%	4,839,524	2,598,287	86.3%
2024/06	848,423	509,165	7.3%	66.6%	3,959,921	2,152,482	84%
2024/05	790,639	418,256	18.5%	89%	3,111,498	1,643,317	89.3%
2024/04	667,420	337,413	19.6%	97.8%	2,320,859	1,225,061	89.4%
2024/03	558,040	347,660	-5.1%	60.5%	1,653,438	887,647	86.3%
2024/02	587,814	307,618	15.8%	91.1%	1,095,399	539,988	102.8%
2024/01	507,585	232,370	-24.8%	118.4%	507,585	232,370	118.4%
2023/12	674,560	250,922	58.8%	168.8%	5,105,615	2,882,042	77.2%
2023/11	424,890	315,947	-22.4%	34.5%	4,431,055	2,631,119	68.4%
2023/10	547,405	274,863	36.2%	99.2%	4,006,165	2,315,172	73%
2023/09	401,815	255,151	-12.4%	57.5%	3,458,760	2,040,309	69.5%
2023/08	458,657	207,200	2.9%	121.3%	3,056,944	1,785,158	71.2%
2023/07	445,805	348,489	-12.4%	27.9%	2,598,287	1,577,958	64.7%
2023/06	509,165	276,669	21.7%	84%	2,152,482	1,229,469	75.1%
2023/05	418,256	347,722	24%	20.3%	1,643,317	952,800	72.5%
2023/04	337,413	353,334	-2.9%	-4.5%	1,225,061	605,078	102.5%
2023/03	347,660	132,070	13%	163.2%	887,647	251,744	252.6%
2023/02	307,618	55,023	32.4%	459.1%	539,988	119,674	351.2%
2023/01	232,370	64,651	-7.4%	259.4%	232,370	64,651	259.4%
2022/12	250,922	111,793	-20.6%	124.4%	2,882,042	656,043	339.3%
2022/11	315,947	225,350	14.9%	40.2%	2,631,119	544,250	383.4%
2022/10	274,863	42,398	7.7%	548.3%	2,315,172	318,900	626%
2022/09	255,151	27,678	23.1%	821.8%	2,040,309	276,502	637.9%
2022/08	207,200	30,766	-40.5%	573.5%	1,785,158	248,824	617.4%
2022/07	348,489	33,618	26%	936.6%	1,577,958	218,058	623.6%
2022/06	276,669	24,620	-20.4%	1023.8%	1,229,469	184,440	566.6%